(Q47253159)

English

Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators

scientific article published in November 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

Eugene Braunwald

12

object named as

Braunwald E

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

Sabina A Murphy

3

object named as

Murphy SA

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

W. Douglas Weaver

10

object named as

Weaver WD

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

author name string

Gibson CM

1

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Cannon CP

2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Adgey AA

4

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Schweiger MJ

5

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Sequeira RF

6

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Grollier G

7

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Fox NL

8

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Berioli S

9

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Van de Werf F

11

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

84

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

9

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

976-980

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

TIMI frame count: a quantitative method of assessing coronary artery flow

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

Thrombolysis in Myocardial Infarction frame count in saphenous vein grafts.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

Impact of injection rate on the Thrombolysis in Myocardial Infarction (TIMI) trial frame count

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flow

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

The corrected TIMI frame count. The new gold standard?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900483-X

7 January 2021

Identifiers

10.1016/S0002-9149(99)00483-X

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10569649

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47253159&oldid=2148028706"